Overview
AI-driven small molecule design now part of Recursion.
Details
Valence Labs builds geometric deep learning for drug design and was acquired by Recursion in 2023.
Tags
drug-discovery, geometric-deep-learning, recursion, small-molecule
Valence Discovery (Recursion)
AI-driven small molecule design now part of Recursion. Valence Labs builds geometric deep learning for drug design and was acquired by Recursion in 2023.
Visit Website
Drug Discovery & Pharma
drug-discovery geometric-deep-learning recursion small-molecule